Company news
Bluejay Diagnostics, Inc. news in 2022
Bluejay Diagnostics, Inc.'s news releases, calls and decks from 2022, newest first.
Bluejay Diagnostics, Inc. Reports Third Quarter 2022 Financial Results
November 8, 2022
Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results
July 25, 2022
Bluejay Completes Planned Clinical Studies for Symphony IL-6 Test
July 5, 2022
Bluejay Reports FDA Agrees to Consider its Plan to Pursue a De Novo Regulatory Pathway for the Symphony IL-6 Test
June 8, 2022
Bluejay Diagnostics, Inc. Reports First Quarter 2022 Financial Results
April 19, 2022
Bluejay Diagnostics Appoints Edwin Rule as Vice President, Regulatory, Quality and Compliance
March 27, 2022
Bluejay Diagnostics Appoints Kenneth Fisher as Chief Financial Officer
March 23, 2022
Bluejay Diagnostics, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
March 9, 2022
Bluejay Diagnostics, Inc. Announces its Pre-Submission Filing Package for the Symphony IL-6 Test is with the FDA
January 30, 2022
Bluejay Diagnostics, Inc. Completes 90 Subjects in Multicenter Clinical Study Addressing Rapid IL-6 Test for COVID-19 Patients in Critical Care
January 12, 2022
Bluejay Diagnostics, Inc. Appoints Mark Feinberg, M.D. as Chief Medical Advisor
January 4, 2022